VYOME HOLDINGS, INC. Business Combination, Acquisition Related Costs
VYOME HOLDINGS, INC. (HIND) reported Business Combination, Acquisition Related Costs of $711.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2025-08-14
- VYOME HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2025-06-30 was $711.00K, a 233.80% increase year-over-year.
- VYOME HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2025-03-31 was $367.00K.
- VYOME HOLDINGS, INC. business combination, acquisition related costs for the quarter ending 2024-06-30 was $213.00K.
- VYOME HOLDINGS, INC. business combination, acquisition related costs for fiscal 2024 was $1.02M.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|
| 2025-06-30 | $711.00K 10-Q · filed 2025-08-14 | $1.04M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $367.00K 10-Q · filed 2025-05-20 | ||
| 2024-12-31 | $1.02M 10-K · filed 2025-04-04 | ||
| 2024-06-30 | $213.00K 10-Q · filed 2025-08-14 | $325.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |